Winfried Kern to Treatment Outcome
This is a "connection" page, showing publications Winfried Kern has written about Treatment Outcome.
Connection Strength
0.077
-
[Hospital Antibiotic Stewardship - New Guidelines and New Findings]. Dtsch Med Wochenschr. 2017 Feb; 142(3):177-182.
Score: 0.025
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.008
-
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis. Front Immunol. 2020; 11:2086.
Score: 0.008
-
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
Score: 0.008
-
Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania. PLoS Negl Trop Dis. 2018 10; 12(10):e0006844.
Score: 0.007
-
Staphylococcus aureus bloodstream infection in patients with ventricular assist devices-Management and outcome in a prospective bicenter cohort. J Infect. 2018 07; 77(1):30-37.
Score: 0.007
-
Answer to February 2018 Photo Quiz. J Clin Microbiol. 2018 02; 56(2).
Score: 0.007
-
Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials. J Infect. 2017 03; 74(3):248-259.
Score: 0.006